Overview


According to FutureWise analysis the market for facial aesthetics in 2023 is US$ 8.34 billion, and is expected to reach US$ 26.83 billion by 2031 at a CAGR of 15.72%.

Facial aesthetic treatment addresses these side effects of aging by restoring skin's vigor to its earlier state. The procedure involves lifting and smoothening the skin, particularly that of the face, without undergoing surgery. Treatments for facial aesthetics can remove frown lines, crow's feet. In order to improve lip, cheek, and chin areas of the face, derma fillers are the best option. After the derma filler is injected into the skin, a numbing solution is applied to the area to make it more comfortable for the patient. Once the derma filler has taken effect, the skin has a smoother appearance. In facial aesthetic treatment, there are neither cuts nor incisions, which makes it the best cosmetic treatment. The goal of facial aesthetics is to treat skin conditions such as scars, acne, hyperpigmentation, wrinkles, dark skin, and stretch marks without invasive methods or chemicals.

To improve aesthetic appearance, a number of facial aesthetic procedures are available, including cosmetic implants, chemical peels, dermal fillers, botulinum toxin, microdermabrasion, and injections of botulinum toxin.There are several types of fillers commonly used during aesthetic procedures, including hyaluronic acid (HA), calcium hydroxyapatite (CaHA), poly-L-lactic acid (PLLA), and polymethyl-methacrylate microspheres (PMMA). The skin can be rejuvenated without undergoing surgery with this type of nonsurgical treatment. Face aesthetics are fast, simple, and inexpensive compared to other types of cosmetic surgery. It is a positive first step for women to adopt a wide range of medical aesthetic treatments. As well, it has attracted an enormous following from patients who might never have considered restorative surgery but are very pleased with the quick and short-term results. It is possible to restore the skin's natural youthful appearance by using dermal fillers. There is a high level of demand in the end-user segment, along with a wider range of facial aesthetic products for treating more and more parts of the face, and the average patient spend in dermatology and beauty clinics is increasing at a very healthy rate, especially in developed nations.

As a cosmetic treatment, facial aesthetics enhances your natural beauty and highlights your facial characteristics. The purpose of these treatments is to restore facial symmetry, tighten drooping skin, and combat signs of aging on your skin. In order to restore a youthful appearance to the skin, dermal fillers may be used. As a result, end-user demand is high, and more and more facial aesthetic products are being developed to treat more and more parts of the face, and dermatology and beauty clinics are increasing their average patient spend at a healthier rate, especially in industrialized countries. In the facial aesthetics market, end-users include aesthetic clinics, hospitals, and beauty salons.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Facial Aesthetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Facial Aesthetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbvie Inc
  • Merz Pharma
  • Galderma Laboratories I.p.
  • Candela Syneron
  • Vital Esthetique
  • Teoxane
  • Johnson and Johnson
  • Cynosure
  • Bausch Health Companies Inc
  • Sinclair Pharmaceuticals Limited
  • ipsen
  • Fotona D.O.O
  • Elan aesthetics
  • Anika Therapeutics Inc
  • Cutera Inc
  • Evolus Inc
  • Revance Therapeutics

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Dermal Fillers
  • Botulinum toxin
  • Microdermabrasion
  • Chemical Peels
  • Others

By Application

  • Facial Line Correction Treatment
  • Scar Treatment
  • Lip Enhancements
  • Restoration of volume or fullness
  • Others

By End-User

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Facial Aesthetics Market By Product, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Facial Aesthetics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Facial Aesthetics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Facial Aesthetics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Facial Aesthetics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dermal Fillers
        2. Botulinum toxin
        3. Microdermabrasion
        4. Chemical Peels
        5. Others

  • 8.   Facial Aesthetics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Facial Line Correction Treatment
        2. Scar Treatment
        3. Lip Enhancements
        4. Restoration of volume or fullness
        5. Others

  • 9.   Facial Aesthetics Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Specialty and Dermatology Clinics
        2. Hospitals
        3. Others

  • 10.   North America Facial Aesthetics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Facial Aesthetics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Facial Aesthetics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Facial Aesthetics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbvie Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merz Pharma
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Galderma Laboratories I.p.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Candela Syneron
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Vital Esthetique
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Teoxane
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Johnson and Johnson
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cynosure
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bausch Health Companies Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sinclair Pharmaceuticals Limited
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. ipsen
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Fotona D.O.O
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Elan aesthetics
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Anika Therapeutics Inc
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Cutera Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Evolus Inc
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
        17. Revance Therapeutics
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients